Results from a recent (relatively small) cohort study comparing patients with obesity (n = 20) and patients with obesity and NASH (n = 17) demonstrated that ACE2 and TMPRSS2 are upregulated in the liver of patients with NASH,88 making the liver another potential target organ for SARS‐CoV‐2 infection. Here, TMPRSS2 is linked to metabolic dysfunction-associated steatohepatitis.